PRO DEX INC (PDEX) research
PRO DEX INC- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Last price
- $64.07
- As of
PRO DEX INC (PDEX): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-18.
As of . Source: SEC EDGAR filings for PDEX. Method and limitations.
Share the PDEX intelligence card
See the full PDEX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PDEX on one page. Preview it with sample data, then open it live with a free account.
Preview the PDEX dossierActive signals for PDEX
- mediumEARNINGS_BEAT
Q4-2026: Beat consensus by 27.3%, EPS $0.87 vs $0.6834 estimate
- mediumNEW_POSITION
MILLENNIUM MANAGEMENT LLC new position in PDEX
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 174.5% - EPS $1.4 vs $0.51 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 24.9% - EPS $0.36 vs $0.4794 estimate
- mediumEARNINGS_BEAT
Beat consensus by 174.5% - EPS $1.4 vs $0.51 estimate
FREE, NO ACCOUNT
Every signal on PDEX, as it fires
You are seeing 5 of 7 signals recorded on PDEX since 2026-06-02.
The five above landed across 4 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in PDEX (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 74265M205 · 2026Q2 | $280K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, PDEX
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
PDEX against its peers
PDEX's operating margin of 16.8% ranks in the 87th percentile of 18 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | PDEX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 77.5M USD | 32.4M USD | 69 | 17 |
| Gross margin | 31.4% | 57.7% | 22 | 15 |
| Operating margin | 16.8% | -59.3% | 87 | 18 |
| Net margin | 17.6% | -61.8% | 87 | 18 |
| Return on equity | 28.7% | -50.7% | 98 | 19 |
| P / E | 15.6x | n/a | n/a | 2 |
Peers (20): UTMD, NNNN, OSUR, NYXH, KRMD, SMTI, STXS, MBOT, AVR, POCI, NEPH, MLSS, HBIO, KMTS, BLFS, RVP, FEMY, BNGO, CUPR, RGNT. Left out: ZJYL (period gap), EMBC (period gap), DXR (no annual filing), ZTEK (no annual filing), AZTA (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (PDEX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more PDEX signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PDEXand get the insider, 13F, options, and confluence read in one view.